Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 62,381 | 74,590 | 56,561 | 71,238 | 6,212 |
| Cost of Goods | 86 | 4,544 | N/A | N/A | N/A |
| Gross Profit | 62,295 | 70,046 | 56,561 | 71,238 | 6,212 |
| Operating Expenses | 96,738 | 84,327 | 83,726 | 103,518 | 53,192 |
| Operating Income | -34,357 | -13,737 | -27,165 | -32,280 | -46,980 |
| Other Income | 504 | 286 | 2,433 | 3,225 | 3,362 |
| Pre-tax Income | -33,853 | -13,451 | -24,732 | -29,056 | -43,618 |
| Net Income Continuous | -33,853 | -13,451 | -24,732 | -29,056 | -43,618 |
| Net Income | $-33,853 | $-13,451 | $-24,732 | $-29,056 | $-43,618 |
| EPS Basic Total Ops | -0.76 | -0.35 | -0.65 | -0.89 | -1.50 |
| EPS Basic Continuous Ops | -0.76 | -0.35 | -0.65 | -0.89 | -1.50 |
| EPS Diluted Total Ops | -0.76 | -0.35 | -0.65 | -0.89 | -1.50 |
| EPS Diluted Continuous Ops | -0.76 | -0.35 | -0.65 | -0.89 | -1.50 |
| EBITDA(a) | $-32,090 | $-12,124 | $-25,539 | $-30,910 | $-46,170 |